24.09.2014 • News

Codexis Appoints Kathleen Glaub to Board of Directors

Kathleen Sereda Glaub has been appointed to Codexis' board of directors. Her 30-year career in leadership positions with drug development and technology companies is expected to bring strong company-building and business strategy experience to the Codexis board.

Glaub has recently been appointed as CEO of Afferent Pharmaceuticals, a clinical-stage biotechnology company that is developing treatments for respiratory and urologic disorders and chronic pain, where she has been a member of its board of directors since 2013. Prior to Afferent, Glaub held positions at Plexxikon, Cell Genesys, Genentech, and Intel.

Codexis

Interview

Building Green Practices Across the Chemical Supply Chain

Driving Sustainability Through Collaboration

Together for Sustainability (TfS) is a pioneering, member-led initiative working to accelerate sustainable and resilient chemical supply chains. TfS President Jennifer Jewson discusses the origins of TfS, its evolving goals, its present-day challenges, and the initiative’s enduring impact and outlook for the future.

Interview

The Path to Sustainable Growth

Leading Transformation

As Executive Vice President of International Chemicals since early 2024, Antje Gerber has been steering Sasol through a pivotal reset—focused on resilience, innovation, and bold sustainability goals.